4.3 Article

Recombinant ecto-5′-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Physiology

Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice

Xiaoyang Hua et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli

John K. Crane et al.

PURINERGIC SIGNALLING (2007)

Review Biotechnology & Applied Microbiology

Adenosine receptors as therapeutic targets

KA Jacobson et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Review Pharmacology & Pharmacy

The 5′-nucleotidases as regulators of nucleotide and drug metabolism

SA Hunsucker et al.

PHARMACOLOGY & THERAPEUTICS (2005)

Article Biology

An electronic pressure-meter nociception paw test for mice

TM Cunha et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)

Article Immunology

Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia

LF Thompson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Article Biochemistry & Molecular Biology

Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling

M Inoue et al.

NATURE MEDICINE (2004)

Review Pharmacology & Pharmacy

Spinal delivery of analgesics in experimental models of pain and analgesia

CA Fairbanks

ADVANCED DRUG DELIVERY REVIEWS (2003)

Review Neurosciences

Adenosine in the spinal cord and periphery: release and regulation of pain

J Sawynok et al.

PROGRESS IN NEUROBIOLOGY (2003)

Article Multidisciplinary Sciences

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor

B Johansson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Pharmacology & Pharmacy

Therapeutic potential of adenosine kinase inhibitors

EA Kowaluk et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)